These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35474739)

  • 21. SARS-CoV-2 RNA load and detection rate in exhaled breath condensate collected from COVID-19 patients infected with Delta variant.
    Sawano M; Takeshita K; Ohno H; Oka H
    J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35580553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.
    Ghosh AK; Kaiser M; Molla MMA; Nafisa T; Yeasmin M; Ratul RH; Sharif MM; Akram A; Hosen N; Mamunur R; Amin MR; Islam A; Hoque ME; Landt O; Lytton SD
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens.
    Ilié M; Benzaquen J; Hofman V; Long-Mira E; Lassalle S; Boutros J; Bontoux C; Lespinet-Fabre V; Bordone O; Tanga V; Allegra M; Salah M; Fayada J; Leroy S; Vassallo M; Touitou I; Courjon J; Contenti J; Carles M; Marquette CH; Hofman P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Viral Loads in Patients With SARS-CoV-2 Delta Variant Infection: Higher Loads Do Not Translate Into Different Testing Scenarios.
    Gomez Marti JL; Mays A; McCullough M; Wells A; Phan T
    Microbiol Insights; 2022; 15():11786361221087537. PubMed ID: 35341107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant.
    Rosato AE; Msiha E; Weng B; Mesisca M; Gnass R; Gnass S; Bol C; Tabuenca A; Rosato RR
    Pathology; 2022 Apr; 54(3):351-356. PubMed ID: 35221043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and Iota.
    Petrone ME; Rothman JE; Breban MI; Ott IM; Russell A; Lasek-Nesselquist E; Badr H; Kelly K; Omerza G; Renzette N; Watkins AE; Kalinich CC; Alpert T; Brito AF; Earnest R; Tikhonova IR; Castaldi C; Kelly JP; Shudt M; Plitnick J; Schneider E; Murphy S; Neal C; Laszlo E; Altajar A; Pearson C; Muyombwe A; Downing R; Razeq J; Niccolai L; Wilson MS; Anderson ML; Wang J; Liu C; Hui P; Mane S; Taylor BP; Hanage WP; Landry ML; Peaper DR; Bilguvar K; Fauver JR; Vogels CBF; Gardner LM; Pitzer VE; St George K; Adams MD; Grubaugh ND
    Commun Biol; 2022 May; 5(1):439. PubMed ID: 35545661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
    Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.
    Kang M; Xin H; Yuan J; Ali ST; Liang Z; Zhang J; Hu T; Lau EH; Zhang Y; Zhang M; Cowling BJ; Li Y; Wu P
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory analysis of two Delta SARS-CoV-2 variant outbreaks in the Port of Antwerp.
    Boogaerts HLF; Smits P; Hans G; Bouly L; Coeck E; Vandamme S; Jansens H; Goossens H; Matheeussen V
    Acta Clin Belg; 2022 Dec; 77(6):925-932. PubMed ID: 34851231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution.
    Sunagawa J; Park H; Kim KS; Komorizono R; Choi S; Ramirez Torres L; Woo J; Jeong YD; Hart WS; Thompson RN; Aihara K; Iwami S; Yamaguchi R
    Nat Commun; 2023 Nov; 14(1):7395. PubMed ID: 37989736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2.
    Levine-Tiefenbrun M; Yelin I; Alapi H; Katz R; Herzel E; Kuint J; Chodick G; Gazit S; Patalon T; Kishony R
    Nat Med; 2021 Dec; 27(12):2108-2110. PubMed ID: 34728830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy.
    De Marco C; Veneziano C; Massacci A; Pallocca M; Marascio N; Quirino A; Barreca GS; Giancotti A; Gallo L; Lamberti AG; Quaresima B; Santamaria G; Biamonte F; Scicchitano S; Trecarichi EM; Russo A; Torella D; Quattrone A; Torti C; Matera G; De Filippo C; Costanzo FS; Viglietto G
    Front Microbiol; 2022; 13():934993. PubMed ID: 35966675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
    Teyssou E; Delagrèverie H; Visseaux B; Lambert-Niclot S; Brichler S; Ferre V; Marot S; Jary A; Todesco E; Schnuriger A; Ghidaoui E; Abdi B; Akhavan S; Houhou-Fidouh N; Charpentier C; Morand-Joubert L; Boutolleau D; Descamps D; Calvez V; Marcelin AG; Soulie C
    J Infect; 2021 Oct; 83(4):e1-e3. PubMed ID: 34419559
    [No Abstract]   [Full Text] [Related]  

  • 35. Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics.
    Oh C; Sashittal P; Zhou A; Wang L; El-Kebir M; Nguyen TH
    Appl Environ Microbiol; 2022 Apr; 88(7):e0228921. PubMed ID: 35285246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phylodynamic analysis of SARS-CoV-2 spread in Rio de Janeiro, Brazil, highlights how metropolitan areas act as dispersal hubs for new variants.
    Lamarca AP; de Almeida LGP; Francisco RDS; Cavalcante L; Brustolini O; Gerber AL; Guimarães APC; de Oliveira TH; Dos Santos Nascimento ÉR; Policarpo C; de Souza IV; de Carvalho EM; Ribeiro MS; Carvalho S; Dias da Silva F; de Oliveira Garcia MH; de Souza LM; Da Silva CG; Ribeiro CLP; Cavalcanti AC; de Mello CMB; Tanuri A; Vasconcelos ATR
    Microb Genom; 2022 Sep; 8(9):. PubMed ID: 36106981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections.
    Siedner MJ; Boucau J; Gilbert RF; Uddin R; Luu J; Haneuse S; Vyas T; Reynolds Z; Iyer S; Chamberlin GC; Goldstein RH; North CM; Sacks CA; Regan J; Flynn JP; Choudhary MC; Vyas JM; Barczak AK; Lemieux JE; Li JZ
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34871181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Earlier
    Lebourgeois S; Chenane HR; Houhou-Fidouh N; Menidjel R; Ferré VM; Collin G; Benmalek N; Coppée R; Larrouy L; Yazdanpanah Y; Timsit JF; Charpentier C; Descamps D; Visseaux B
    Front Cell Infect Microbiol; 2021; 11():792202. PubMed ID: 34976868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
    Galloway SE; Paul P; MacCannell DR; Johansson MA; Brooks JT; MacNeil A; Slayton RB; Tong S; Silk BJ; Armstrong GL; Biggerstaff M; Dugan VG
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):95-99. PubMed ID: 33476315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.